2496 SpoIIaa-like
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Homogeneous metal compounds | 6 | 11.1 | 0.54× | q = 0.06 | |
| Nucleosides, nucleotides, and analogues | 2 | 6.3 | 0.32× | q = 0.09 | |
| Hydrocarbons | 1 | 0.2 | 6.31× | not tested | |
| Organosulfur compounds | 2 | 0.5 | 4.29× | not tested | |
| Lipids and lipid-like molecules | 10 | 2.5 | 3.96× | not tested | |
| Homogeneous non-metal compounds | 11 | 4.9 | 2.25× | not tested | |
| Benzenoids | 2 | 1.7 | 1.21× | not tested | |
| Organic oxygen compounds | 2 | 4.5 | 0.44× | not tested | |
| Organoheterocyclic compounds | 1 | 3.5 | 0.29× | not tested | |
| Organic acids and derivatives | 1 | 3.5 | 0.28× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00163 | VIV | Vitamin E | 16 |
| DB00171 | ATP | ATP | 5 |
| DB16833 | ADP | Adenosine disphosphate | 5 |
| DB03796 | PLM | Palmitic Acid | 3 |
| DB14094 | VTQ | Tocopherylquinone | 3 |
| DB18267 | HEM | Ferroheme | 3 |
| DB02080 | TRT | 1-{2-[2-(2-Methoxyethoxy)Ethoxy]Ethoxy}-4-(1,1,3,3-Tetramethylbutyl)Benzene | 2 |
| DB04327 | PEE | Phosphatidylethanolamine | 2 |
| DB09459 | TLA | L-tartaric acid | 2 |
| DB11460 | SQL | Squalene | 2 |
| DB14001 | — | — | 2 |
| DB14002 | — | — | 2 |
| DB16857 | 11A | Undecanoic acid | 2 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| CL | CHLORIDE ION | 18 |
| VIV | (2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL | 13 |
| B7N | (1R)-2-{[(S)-hydroxy{[(1S,2R,3R,4S,5S,6R)-2,3,4,5,6-pentahydroxycyclohexyl]oxy}phosphoryl]oxy}-1-[(octadecanoyloxy)methyl]ethyl (9Z)-octadec-9-enoate | 7 |
| NAmetal | SODIUM ION | 7 |
| IOD | IODIDE ION | 6 |
| LBN | 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine | 6 |
| ATP | ADENOSINE-5'-TRIPHOSPHATE | 5 |
| PEV | (1S)-2-{[(2-AMINOETHOXY)(HYDROXY)PHOSPHORYL]OXY}-1-[(PALMITOYLOXY)METHYL]ETHYL STEARATE | 5 |
| 3PT | (2R)-3-{[(S)-hydroxy{[(1S,2R,3R,4S,5S,6S)-2,3,6-trihydroxy-4,5-bis(phosphonooxy)cyclohexyl]oxy}phosphoryl]oxy}propane-1,2-diyl dibutanoate | 4 |
| C14 | TETRADECANE | 4 |
| D10 | DECANE | 4 |
| NImetal | NICKEL (II) ION | 4 |
| OCT | N-OCTANE | 4 |
| POP | PYROPHOSPHATE 2- | 4 |
| PTY | PHOSPHATIDYLETHANOLAMINE | 4 |
| RET | RETINAL | 4 |
| 6PL | (4S,7R)-4-HYDROXY-N,N,N-TRIMETHYL-9-OXO-7-[(PALMITOYLOXY)METHYL]-3,5,8-TRIOXA-4-PHOSPHAHEXACOSAN-1-AMINIUM 4-OXIDE | 3 |
| HEM | PROTOPORPHYRIN IX CONTAINING FE | 3 |
| MGmetal | MAGNESIUM ION | 3 |
| PBU | (2R)-3-{[(R)-HYDROXY{[(1R,2R,3S,4R,5R,6S)-2,3,6-TRIHYDROXY-4,5-BIS(PHOSPHONOOXY)CYCLOHEXYL]OXY}PHOSPHORYL]OXY}PROPANE-1,2-DIYL DIBUTANOATE | 3 |